Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minwei Yang

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 3, 2019
Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resectionJianyu Yang, Junfeng Zhang, Wei Lui, et al.
Carcinogenesis|May 13, 2022
HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathwayJiao Li, Jing Chang, Jinghan Wang, et al.
Theranostics|July 30, 2020
Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic CancerJunfeng Zhang, Jianyu Yang, Chaoyi Lin, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 23, 2015
High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinomaYanmiao Huo, Minwei Yang, Wei Liu, et al.
Oncology Letters|May 31, 2018
Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patientsWei Liu, Yanmiao Huo, Jianyu Yang, et al.
Oncology Letters|August 11, 2020
Molecular markers associated with perineural invasion in pancreatic ductal adenocarcinomaJunfeng Zhang, Xueliang Fu, Dejun Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
A malignant subpopulation of H2AFZ+ cells interacts with myeloid cells to promote an anti-inflammatory microenvironment and drive hepatic metastasis, revealing an immunotherapeutic strategy for pancreatic ductal adenocarcinomaJianyu Yang, Wanhong Chen, Zonghao Duan, et al.
International Journal of Biological Sciences|March 14, 2025
TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axisYifan Yin, Yixuan Sun, Hongfei Yao, et al.
Scientific Reports|March 10, 2025
Serum microRNA-24-based nomogram predicts prognosis for patients with resected pancreatic cancerJing Huang, Qian Zhang, Yang Ge, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2023
Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinomaYongsheng Jiang, Lijie Han, Jian Yang, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 3, 2019
Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resectionJianyu Yang, Junfeng Zhang, Wei Lui, et al.
Carcinogenesis|May 13, 2022
HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathwayJiao Li, Jing Chang, Jinghan Wang, et al.
Theranostics|July 30, 2020
Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic CancerJunfeng Zhang, Jianyu Yang, Chaoyi Lin, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 23, 2015
High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinomaYanmiao Huo, Minwei Yang, Wei Liu, et al.
Oncology Letters|May 31, 2018
Decreased expression of USP9X is associated with poor prognosis in Chinese pancreatic ductal adenocarcinoma patientsWei Liu, Yanmiao Huo, Jianyu Yang, et al.
Oncology Letters|August 11, 2020
Molecular markers associated with perineural invasion in pancreatic ductal adenocarcinomaJunfeng Zhang, Xueliang Fu, Dejun Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2026
A malignant subpopulation of H2AFZ+ cells interacts with myeloid cells to promote an anti-inflammatory microenvironment and drive hepatic metastasis, revealing an immunotherapeutic strategy for pancreatic ductal adenocarcinomaJianyu Yang, Wanhong Chen, Zonghao Duan, et al.
International Journal of Biological Sciences|March 14, 2025
TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the β-catenin-c-MYC-GLUT1 axisYifan Yin, Yixuan Sun, Hongfei Yao, et al.
Scientific Reports|March 10, 2025
Serum microRNA-24-based nomogram predicts prognosis for patients with resected pancreatic cancerJing Huang, Qian Zhang, Yang Ge, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2023
Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinomaYongsheng Jiang, Lijie Han, Jian Yang, et al.
Pageof 4